MORRISVILLE, N.C., March 31, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced the Board of Directors accepted the resignation of President and Chief Operating Officer Richard Kiral, Ph.D., effective Friday, April 1, 2011. Dr. Kiral will complete his term on the Board of Directors, however, he will not seek reelection during the annual shareholder meeting held in September. To affect a smooth transition, Dr. Kiral and the company have entered into a two-year consulting agreement.
